NCT00384384View on ClinicalTrials.gov

Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

April 30, 2007

Conditions
End Stage Renal Disease
Interventions
DRUG

oral 18B Glycyrrhetinic acid versus placebo

Trial Locations (1)

3010

Department of nephrology and hypertension, University hospital of berne, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT00384384 - Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients | Biotech Hunter | Biotech Hunter